Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Providing Positive Outcomes through Compounding for Animal Cancer Patients

Author(s):  Davidson Gigi S

Issue:  Jul/Aug 2000 - Compounding for Hospice and Cancer Patients
View All Articles in Issue

Abstract:  The role of the compounding pharmacist is critical during the treatment of animals with cancer. In this article, the author discusses methods of therapy, considerations for extrapolation of therapies, chemoresponsive tumors (lymphoma, mast cell tumor, osteosarcoma, bladder cancer, postvaccinal sarcomas, equine tumors, sarcoids, squamous cell carcinoma and melanoma), specific intralesional and topical chemotherapy and immunotherapy, adverse sequelae to cancer treatment in animal patients, therapeutic options for pain in the cancer patient and frontiers of veterinary cancer therapy. She also provides tables with the following information: a chart showing conversion of body weight in kilograms to body surface area in meters squared for dogs, a chart showing conversion of body weight in kilograms to body surface area in meters squared for cats, compounded cancer treatment options for oral administration, considerations for extrapolation of human therapies to animal patients, a treatment protocol for canine lymphoma, a feline lymphoma treatment protocol, canine mast cell tumor treatment options, a canine osteosarcoma treatment protocol, a feline vaccine-associated sarcoma treatment protocol, equine sarcoid treatment options, equine squamous cell carcinoma treatment options, equine melanoma treatment options, compounded intralesional and topical chemotherapeutic agents, treatment options for adverse sequelae to cancer treatment and therapeutic options for pain management in the veterinary cancer patient.

Related Keywords: animal patients, animals, antineoplastic, bladder cancer, cancer, cat, chemotherapy, cytotoxic, dog, equine tumors, horse, immunotherapy, lyphoma, mast cell tumor, melanoma, oncolgists, osteosarcoma, pets, postvaccinal sarcomas, sarcoids, squamous cell carcinoma, veterinary


Printer-Friendly Version

Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Providing Positive Outcomes through Compounding for Animal Cancer Patients Davidson Gigi S Jul/Aug 2000 264-272 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106-113 Buy
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Pope George, Daleo Charles, Batson SL Sep/Oct 2019 358-364 Buy
Compounding for Cancer in Companion Animals Mixon William, Northrup Nicole, Vail Jane Jan/Feb 2009 42-49 Buy
Compounding Antiangiogenic Cancer Therapy for Animals Davidson Gigi S May/Jun 2005 195-198 Buy
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr Mar/Apr 2004 126-129 Buy
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease Patterson Donna, Ford Peter R, Gallon Marlene D Jul/Aug 1997 242-243 Buy
Drugs Banned for Use in Food Animals: An Explanation Davidson Gigi S Mar/Apr 2001 101-103 Buy
The Use of Psychoactive Agents in Veterinary Medicine Simpson Barbara S Mar/Apr 2001 86-88 Buy
Compounding Prokinetic Medications for Companion Animals Gaskins Jessica Jul/Aug 2012 276-286 Buy